News

Joint malaria research

Bayer CropScience signs research agreement with charity

Professor Friedrich Berschauer, Chairman of the Board of Management of Bayer CropScience, and Professor Janet Hemingway, Chief Executive Officer, IVCC, at the signing of the research agreement.

Zoom image

Professor Friedrich Berschauer, Chairman of the Board of Management of Bayer CropScience, and Professor Janet Hemingway, Chief Executive Officer, IVCC, at the signing of the research agreement.

Bayer CropScience and the Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom, plan to jointly develop new active ingredients against mosquitoes that transmit diseases such as malaria and are resistant to conventional insecticides.

Resistance to active substances is currently one of the biggest problems in the battle against malaria. The project aims to discover new active ingredients for public health products (PHPs) that help protect people against diseases by controlling the insects that transmit them.

The partners signed a research agreement in May that will initially run for three years. Bayer CropScience will contribute to the project its extensive library of substances and screening capabilities, along with its experience in chemical synthesis and insecticides research and development.

Initially established as a research consortium in 2005, the IVCC has evolved into a product development partnership (PDP). In 2008 it received the status of a not-for-profit company and registered charity.